ProCE Banner Activity

The Evolving Treatment Landscape of Follicular Lymphoma: Focus on BTK Inhibition

Video

Hear Christopher Flowers, a leading clinician in B-cell malignancies, for an update in the treatment of follicular lymphoma. Dr Flowers reviews the pivotal ROSEWOOD data for the BTK inhibitor zanubrutinib in the treatment of relapsed/refractory follicular lymphoma and discusses potential implications on patient care.

Released: April 10, 2024

Expiration: July 30, 2024